Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.

Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. · 2020

Read Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. by Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7426526.txt.

Description

Walcher and co-authors review cancer stem cells, a small tumor cell group that can start tumors and drive relapse. These cells can arise from mature cells or from adult stem cells in tissue. Their markers help doctors judge diagnosis, treatment, and outlook.

The review lists the most used markers in deadly solid cancers such as lung, stomach, liver, breast, and colorectal cancers. It also covers markers in acute and chronic myeloid leukemia. Chemo and radiation can change the markers and push cells toward stem-like states. Senescent tumor cells can aid shrinkage yet later fuel relapse. The authors urge tracking leftover stem cells after therapy. Targeted immune strategies may one day clear them.

Catalog record

CREATORWalcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE196 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7426526

Browse the full library · About the Tower of Babel